Intervention Review

Valproate for schizophrenia

  1. Christian Schwarz1,*,
  2. Anja Volz2,
  3. Chunbo Li3,
  4. Stefan Leucht4

Editorial Group: Cochrane Schizophrenia Group

Published Online: 16 JUL 2008

Assessed as up-to-date: 4 MAY 2008

DOI: 10.1002/14651858.CD004028.pub3

How to Cite

Schwarz C, Volz A, Li C, Leucht S. Valproate for schizophrenia. Cochrane Database of Systematic Reviews 2008, Issue 3. Art. No.: CD004028. DOI: 10.1002/14651858.CD004028.pub3.

Author Information

  1. 1

    Technische Universität München, Psychiatry and Psychotherapy, Munich, Germany

  2. 2

    Klinikum rechts der Isar der TU-München, Klinik für Psychiatrie und Psychotherapie, München, Germany

  3. 3

    Shanghai Mental Health Centre, Shanghai Jiao Tong University School of Medicine, Department of Biological Psychiatry, Shanghai, China

  4. 4

    Technische Universität München Klinikum rechts der Isar, Klinik und Poliklinik für Psychiatrie und Psychotherapie, München, Germany

*Christian Schwarz, Psychiatry and Psychotherapy, Technische Universität München, Möhlstr. 28, Munich, 81675, Germany.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 16 JUL 2008


Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens


Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.